RecruitingAphasiaStrokeStroke Rehabilitation
Telerehabilitation for Aphasia (TERRA)
Eligible age
21–80 yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
Speech-language therapy is generally found to be helpful in the rehabilitation of aphasia. However, not all patients with aphasia have access to adequate treatment to maximize their recovery. The goal of this project is to compare the efficacy of telerehabilitation or Aphasia Remote Therapy (ART) to the more traditional In-Clinic Therapy (I-CT).
Sponsor: University of South Carolina
You may qualify if…
- ✓ 1. Participants must have sustained a left hemisphere ischemic or hemorrhagic stroke at least 12 months prior to enrollment.
- ✓ 2. Participants must primarily speak English for at least the past 20 years.
- ✓ 3. Participants must be capable of giving informed consent or indicating another to provide informed consent.
- ✓ 4. Participants must be between 21-80 years of age.
- ✓ 5. Participants must be magnetic resonance imaging (MRI) compatible (e.g., no metal implants, not claustrophobic) on a 3-Tesla (3T) scanner.
You may not qualify if…
- ✕ 1. Participants must not have previous neurological disease affecting the brain (e.g. history of traumatic brain injury).
- ✕ 2. Participants must not have severely limited speech production (severe unintelligibility) and/or auditory comprehension that interferes with adequate participation in the therapy provided (i.e., WAB-R Spontaneous Speech rating scale score of 0-1 or WAB-R Comprehension score of 0-1).
- ✕ 3. Participants must not have a history of stroke to the right hemisphere of the brain.
- ✕ 4. Participants must not have a bilateral, cerebellar or brainstem stroke.
- ✕ 5. Participants must not have anything that makes them be 3T MRI incompatible
- ✕ 6. Insufficient intelligible speech to provide accurate responses with discourse/naming.
Where it's recruiting
South Carolina
Columbia
Source: ClinicalTrials.gov · NCT04682223 · last updated 2026-04-02